These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24524963)

  • 1. BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease.
    Del Campo M; Hoozemans JJ; Dekkers LL; Rozemuller AJ; Korth C; Müller-Schiffmann A; Scheltens P; Blankenstein MA; Jimenez CR; Veerhuis R; Teunissen CE
    Neurobiol Aging; 2014 Jul; 35(7):1596-604. PubMed ID: 24524963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of BRI2-BRICHOS ectodomain correlates with a decreased clearance of Aβ by insulin degrading enzyme (IDE) in Alzheimer's disease.
    Del Campo M; Stargardt A; Veerhuis R; Reits E; Teunissen CE
    Neurosci Lett; 2015 Mar; 589():47-51. PubMed ID: 25597881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (Abeta1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Abeta aggregation.
    Peng S; Fitzen M; Jörnvall H; Johansson J
    Biochem Biophys Res Commun; 2010 Mar; 393(3):356-61. PubMed ID: 20036644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells.
    Del Campo M; Oliveira CR; Scheper W; Zwart R; Korth C; Müller-Schiffmann A; Kostallas G; Biverstal H; Presto J; Johansson J; Hoozemans JJ; Pereira CF; Teunissen CE
    Cell Mol Life Sci; 2015 Apr; 72(8):1599-611. PubMed ID: 25336154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia-related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Aβ42 toxicity in Drosophila.
    Poska H; Haslbeck M; Kurudenkandy FR; Hermansson E; Chen G; Kostallas G; Abelein A; Biverstål H; Crux S; Fisahn A; Presto J; Johansson J
    Biochem J; 2016 Oct; 473(20):3683-3704. PubMed ID: 27514716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cytoskeletal proteins as binding partners of Bri2 BRICHOS domain.
    Shimozawa M; Tigro H; Biverstål H; Shevchenko G; Bergquist J; Moaddel R; Johansson J; Nilsson P
    Mol Cell Neurosci; 2023 Jun; 125():103843. PubMed ID: 36935047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.
    Philipson O; Lord A; Lalowski M; Soliymani R; Baumann M; Thyberg J; Bogdanovic N; Olofsson T; Tjernberg LO; Ingelsson M; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2012 May; 33(5):1010.e1-13. PubMed ID: 22118948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production.
    Matsuda S; Giliberto L; Matsuda Y; Davies P; McGowan E; Pickford F; Ghiso J; Frangione B; D'Adamio L
    J Biol Chem; 2005 Aug; 280(32):28912-6. PubMed ID: 15983050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous treatment with a molecular chaperone designed against β-amyloid toxicity improves Alzheimer's disease pathology in mouse models.
    Manchanda S; Galan-Acosta L; Abelein A; Tambaro S; Chen G; Nilsson P; Johansson J
    Mol Ther; 2023 Feb; 31(2):487-502. PubMed ID: 35982621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
    Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
    Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
    Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
    Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bri2 and Bri3 BRICHOS Domains Interact Differently with Aβ
    Dolfe L; Tambaro S; Tigro H; Del Campo M; Hoozemans JJM; Wiehager B; Graff C; Winblad B; Ankarcrona M; Kaldmäe M; Teunissen CE; Rönnbäck A; Johansson J; Presto J
    J Alzheimers Dis Rep; 2018 Feb; 2(1):27-39. PubMed ID: 30480246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: cholesterol a menace?
    Mathew A; Yoshida Y; Maekawa T; Kumar DS
    Brain Res Bull; 2011 Aug; 86(1-2):1-12. PubMed ID: 21741455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant BRICHOS chaperone domains delivered to mouse brain parenchyma by focused ultrasound and microbubbles are internalized by hippocampal and cortical neurons.
    Galan-Acosta L; Sierra C; Leppert A; Pouliopoulos AN; Kwon N; Noel RL; Tambaro S; Presto J; Nilsson P; Konofagou EE; Johansson J
    Mol Cell Neurosci; 2020 Jun; 105():103498. PubMed ID: 32389804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice.
    Djogo N; Jakovcevski I; Müller C; Lee HJ; Xu JC; Jakovcevski M; Kügler S; Loers G; Schachner M
    Neurobiol Dis; 2013 Aug; 56():104-15. PubMed ID: 23639788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator arrests Alzheimer's disease pathogenesis.
    Oh SB; Byun CJ; Yun JH; Jo DG; Carmeliet P; Koh JY; Lee JY
    Neurobiol Aging; 2014 Mar; 35(3):511-9. PubMed ID: 24126163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.